203 related articles for article (PubMed ID: 7258018)
1. Effects of antibiotics on the immune system of animals. I. Mouse experiments with the low-virulence VR2 strain of Erysipelothrix rhusiopathiae.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):297-307. PubMed ID: 7258018
[No Abstract] [Full Text] [Related]
2. Effects of antibiotics on the immune system of animals. II. Mouse experiments with an inactivated adsorbed vaccine against swine erysipelas.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):309-16. PubMed ID: 7258019
[No Abstract] [Full Text] [Related]
3. Effect of antibiotics on the immune system of animals. III. Experiments in pgis immunized with live and inactivated swine erysipelas vaccines.
Tu TD
Acta Vet Acad Sci Hung; 1981; 28(3):317-31. PubMed ID: 7258020
[No Abstract] [Full Text] [Related]
4. Cross protection in mice and swine immunized with live erysipelas vaccine to challenge exposure with strains of Erysipelothrix rhusiopathiae of various serotypes.
Takahashi T; Takagi M; Sawada T; Seto K
Am J Vet Res; 1984 Oct; 45(10):2115-8. PubMed ID: 6497110
[TBL] [Abstract][Full Text] [Related]
5. Safety of a live attenuated Erysipelothrix rhusiopathiae vaccine for swine.
Neumann EJ; Grinberg A; Bonistalli KN; Mack HJ; Lehrbach PR; Gibson N
Vet Microbiol; 2009 Mar; 135(3-4):297-303. PubMed ID: 18977618
[TBL] [Abstract][Full Text] [Related]
6. [Immunity of native SpaA and recombinant SpaA-N against Erysipelothrix rhusiopathiae infection in mice].
Nazierbieke W; Zhang L; He C; Peng Q; Borrathybay E
Wei Sheng Wu Xue Bao; 2010 Mar; 50(3):367-72. PubMed ID: 20499642
[TBL] [Abstract][Full Text] [Related]
7. Cross protection of mice and swine given live-organism vaccine against challenge exposure with strains of Erysipelothrix rhusiopathiae representing ten serovars.
Sawada T; Takahashi T
Am J Vet Res; 1987 Jan; 48(1):81-4. PubMed ID: 3826847
[TBL] [Abstract][Full Text] [Related]
8. The development of primary antibacterial immune protection against Erysipelothrix rhusiopathiae and the effect of anaerobic corynebacterial immunostimulants. (Short communication).
Padányi M; Réthy L; Kulcsár A; Géresi M; Gelencsér F; Pogány I; Bácskai L; Réthy LA
Acta Vet Acad Sci Hung; 1981; 28(3):273-5. PubMed ID: 7258016
[No Abstract] [Full Text] [Related]
9. Genome-Wide Identification of Virulence Genes in
Shimoji Y; Ogawa Y; Tsukio M; Shiraiwa K; Nishikawa S; Eguchi M
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548316
[TBL] [Abstract][Full Text] [Related]
10. Development of an enzyme-linked immunosorbent assay for potency testing of erysipelas bacterins.
Henderson LM; Scheevel KF; Walden DM
Dev Biol Stand; 1996; 86():333. PubMed ID: 8785973
[No Abstract] [Full Text] [Related]
11. Susceptibility of vaccinated swine and mice to generalized infection with specific serotypes of Erysipelothrix rhusiopathiae.
Wood RL; Booth GD; Cutlip RC
Am J Vet Res; 1981 Apr; 42(4):608-14. PubMed ID: 6174056
[TBL] [Abstract][Full Text] [Related]
12. Effect of age and maternally-derived antibody status on humoral and cellular immune responses to vaccination of pigs against Erysipelothrix rhusiopathiae.
Pomorska-Mól M; Markowska-Daniel I; Pejsak Z
Vet J; 2012 Oct; 194(1):128-30. PubMed ID: 22498786
[TBL] [Abstract][Full Text] [Related]
13. Erysipelothrix rhusiopathiae: association of Spa-type with serotype and role in protective immunity.
Ingebritson AL; Roth JA; Hauer PJ
Vaccine; 2010 Mar; 28(13):2490-6. PubMed ID: 20117264
[TBL] [Abstract][Full Text] [Related]
14. Growth ability and immunological properties of Erysipelothrix rhusiopathiae serotype 2.
Zarkasie K; Sawada T; Yoshida T; Takahashi I; Takahashi T
J Vet Med Sci; 1996 Jan; 58(1):87-90. PubMed ID: 8645767
[TBL] [Abstract][Full Text] [Related]
15. [Anti-erysipelas vaccine from the VR2 strain].
Majdan S; Krzyszowski M; Kocik T
Veterinariia; 1972 Sep; 9():116-8. PubMed ID: 4667532
[No Abstract] [Full Text] [Related]
16. Vaccination of porpoises (Tursiops truncatus) against Erysipelothrix rhusiopathiae infection.
Gilmartin WG; Allen JF; Ridgway SH
J Wildl Dis; 1971 Oct; 7(4):292-5. PubMed ID: 5163748
[No Abstract] [Full Text] [Related]
17. Genetic and antigenic diversity of the surface protective antigen proteins of Erysipelothrix rhusiopathiae.
To H; Nagai S
Clin Vaccine Immunol; 2007 Jul; 14(7):813-20. PubMed ID: 17475766
[TBL] [Abstract][Full Text] [Related]
18. Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.
Shimoji Y; Mori Y; Sekizaki T; Shibahara T; Yokomizo Y
Infect Immun; 1998 Jul; 66(7):3250-4. PubMed ID: 9632592
[TBL] [Abstract][Full Text] [Related]
19. Cross protection of mice and swine inoculated with culture filtrate of attenuated Erysipelothrix rhusiopathiae and challenge exposed to strains of various serovars.
Sawada T; Takahashi T
Am J Vet Res; 1987 Feb; 48(2):239-42. PubMed ID: 3826862
[TBL] [Abstract][Full Text] [Related]
20. General information about the validation of serological method (ELISA) for the batch potency testing erysipelas vaccines.
Altern Lab Anim; 2002; 30(5):486-7. PubMed ID: 12434771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
